Johnson & Johnson has revealed plans to inject over $55 billion in the United States in the coming four years, leading to the establishment of four new manufacturing plants. This substantial investment aligns with the prioritization of investments in the U.S. by various companies during the Trump administration.

This financial commitment signifies a 25% rise in investment compared to the previous period and is predicted to bring about an annual economic impact exceeding $100 billion within the U.S. region. According to Chairman and CEO Joaquin Duato, the initiative will commence with the construction of an advanced facility in North Carolina, set to both create jobs in the U.S. and produce innovative medicines for patients globally.

Situated in Wilson, near Raleigh, the North Carolina facility is the known location of one of the four new plants, while the whereabouts of the other three remain undisclosed. Johnson & Johnson also plans to expand existing sites, invest in research and development infrastructure, as well as technology improvements.

The company's commitment joins the league of enterprises aiming to bolster their manufacturing footprint in the U.S. Taiwan Semiconductor Manufacturing Co. announced intentions to invest a substantial $100 billion in the U.S., in addition to the $65 billion it had previously committed. Furthermore, Apple's pledge to invest more than $500 billion in the U.S. within the next four years, accompanied by intentions to hire 20,000 employees and establish a new server plant in Texas, indicates a similar trend in domestic investment. One of the significant steps outlined by Apple is the construction of a new factory in Houston, scheduled for 2026, aimed at fabricating servers for its AI suite, Apple Intelligence.